Clinical Trial Update: A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps [Phase 2]

View source ↗

Summary

A phase 2 proof-of-concept trial evaluating Lunsekimig versus placebo in adults with chronic rhinosinusitis with nasal polyps; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Lunsekimig (Lunsekimig)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: ACTIVE_NOT_RECRUITING